positionForPages[218]={page:218,positions:[{w:"loci recurrently involved in genomic rearrangements in these leukemias, such as the im-",p:[0.117647,0.121273,0.852941,0.121273,0.852941,0.100900,0.117647,0.100900,0.005182,0.011276,0.008994,0.005615,0.004040,0.007442,0.009108,0.009108,0.011413,0.007807,0.007442,0.009039,0.011391,0.006617,0.005184,0.009724,0.004040,0.005615,0.011368,0.009633,0.010934,0.005182,0.009633,0.009108,0.011391,0.004040,0.005615,0.011756,0.004040,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.004040,0.007442,0.009291,0.009085,0.007807,0.007898,0.009085,0.011459,0.009656,0.009039,0.017485,0.009039,0.011391,0.006437,0.007670,0.004040,0.005615,0.011756,0.004040,0.006620,0.011299,0.009039,0.007875,0.009039,0.004040,0.005184,0.009128,0.011550,0.010272,0.009039,0.017645,0.005798,0.009291,0.007670,0.004497,0.004040,0.007510,0.011345,0.008765,0.011459,0.004040,0.009291,0.007670,0.004040,0.006620,0.011299,0.009039,0.004040,0.005615,0.017666,0.007533]},{w:"munoglobulin (Ig) and T-cell receptor (TCR) loci, and the KMT2A and SIL-TAL1 fu-",p:[0.117647,0.141852,0.852941,0.141852,0.852941,0.121479,0.117647,0.121479,0.017280,0.011413,0.011596,0.011048,0.009930,0.005182,0.010957,0.010797,0.011550,0.005250,0.005615,0.011756,0.005661,0.006939,0.006483,0.009861,0.006939,0.005661,0.009085,0.011596,0.011391,0.005661,0.011804,0.007533,0.008994,0.008946,0.005387,0.005250,0.005661,0.007442,0.009108,0.008994,0.009128,0.011048,0.006209,0.010843,0.007807,0.005661,0.006825,0.013057,0.014678,0.013376,0.006939,0.005661,0.005182,0.011276,0.008994,0.005341,0.004497,0.005661,0.009085,0.011596,0.011391,0.005661,0.006617,0.011302,0.009039,0.005661,0.014541,0.019608,0.013354,0.010432,0.014929,0.005661,0.009085,0.011596,0.011391,0.005661,0.009770,0.007259,0.011391,0.007533,0.011710,0.014929,0.011619,0.010432,0.005661,0.006369,0.011528,0.007533]},{w:"sion-gene loci. These loci are widely used as PCR-based minimal residual disease (MRD) ",p:[0.117647,0.162431,0.856977,0.162431,0.856977,0.142058,0.117647,0.142058,0.007601,0.005547,0.010843,0.011756,0.007533,0.009656,0.009039,0.011596,0.009039,0.003424,0.005182,0.011276,0.008994,0.005341,0.004497,0.003424,0.011470,0.011311,0.009039,0.007875,0.009039,0.003424,0.005182,0.011276,0.008994,0.005615,0.003424,0.009085,0.007442,0.009039,0.003424,0.014723,0.005547,0.011322,0.008948,0.005182,0.009724,0.003424,0.011413,0.007873,0.009108,0.011391,0.003424,0.009291,0.007670,0.003424,0.012167,0.014678,0.012347,0.007533,0.011117,0.009291,0.007875,0.009108,0.011391,0.003424,0.017645,0.005615,0.011756,0.005615,0.017574,0.009405,0.005250,0.003424,0.007442,0.009039,0.007601,0.005547,0.011048,0.011596,0.009405,0.005250,0.003424,0.011391,0.005615,0.007875,0.009291,0.009291,0.007875,0.009039,0.003424,0.006939,0.019608,0.013376,0.016139,0.006939,0.004109]},{w:"tracing based on the patient-specific rearrangements. We applied our assay to ten acute ",p:[0.117647,0.183009,0.857025,0.183009,0.857025,0.162636,0.117647,0.162636,0.006437,0.007898,0.009291,0.008994,0.005615,0.011459,0.009861,0.004839,0.011117,0.009291,0.007873,0.009108,0.011391,0.004839,0.010843,0.011756,0.004839,0.006620,0.011299,0.009039,0.004839,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007533,0.007510,0.011505,0.009108,0.008994,0.005615,0.005684,0.005613,0.008994,0.004839,0.007442,0.009291,0.009085,0.007807,0.007898,0.009085,0.011459,0.009656,0.009039,0.017485,0.009039,0.011391,0.006437,0.007670,0.004497,0.004839,0.018649,0.009039,0.004839,0.008811,0.011048,0.011162,0.005250,0.005547,0.009108,0.011391,0.004839,0.010820,0.011413,0.007807,0.004839,0.009291,0.007533,0.007941,0.008928,0.009724,0.004839,0.006209,0.011048,0.004839,0.006209,0.009039,0.011756,0.004839,0.009291,0.009108,0.011071,0.006209,0.009039,0.004109]},{w:"lymphoid leukemia samples and showed that we successfully enriched the fusion, Ig and ",p:[0.117647,0.203588,0.856981,0.203588,0.856981,0.183215,0.117647,0.183215,0.005182,0.009724,0.017280,0.011162,0.011299,0.010843,0.005547,0.011391,0.003881,0.005182,0.009131,0.011550,0.010272,0.009039,0.017645,0.005798,0.009291,0.003881,0.007944,0.009085,0.017280,0.011162,0.005182,0.009039,0.007670,0.003881,0.009085,0.011596,0.011391,0.003881,0.007556,0.011299,0.010866,0.014518,0.009108,0.011391,0.003881,0.006620,0.011391,0.008811,0.006437,0.003881,0.014518,0.009039,0.003881,0.007510,0.011345,0.008994,0.008994,0.009039,0.007533,0.007601,0.006369,0.011550,0.005387,0.005182,0.009724,0.003881,0.009039,0.011756,0.007807,0.005547,0.008765,0.011299,0.009108,0.011391,0.003881,0.006620,0.011299,0.009039,0.003881,0.006366,0.011413,0.007601,0.005547,0.010843,0.011756,0.004497,0.003881,0.006483,0.009861,0.003881,0.009085,0.011596,0.011391,0.004109]},{w:"TCR loci. We successfully validated known MRD targets in these patients within two ",p:[0.117647,0.224167,0.857025,0.224167,0.857025,0.203794,0.117647,0.203794,0.013057,0.014678,0.013376,0.006209,0.005182,0.011276,0.008994,0.005341,0.004497,0.006209,0.018649,0.009039,0.006209,0.007510,0.011345,0.008994,0.008994,0.009039,0.007533,0.007601,0.006366,0.011553,0.005385,0.005182,0.009724,0.006209,0.009838,0.009405,0.005250,0.005547,0.011573,0.008811,0.006209,0.009108,0.011391,0.006209,0.010706,0.011596,0.010866,0.014723,0.011756,0.006209,0.019608,0.013376,0.016139,0.006209,0.006549,0.009087,0.007622,0.009658,0.009128,0.006437,0.007670,0.006209,0.005615,0.011756,0.006209,0.006620,0.011299,0.009039,0.007875,0.009039,0.006209,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.006209,0.014723,0.005273,0.006620,0.011459,0.005615,0.011756,0.006209,0.006437,0.014518,0.011048,0.004109]},{w:"days after sample obtention and identified an additional set of patient-specific rearrange-",p:[0.117647,0.244745,0.852941,0.244745,0.852941,0.224373,0.117647,0.224373,0.011573,0.008925,0.009724,0.007670,0.003424,0.009085,0.006197,0.005969,0.009039,0.007807,0.003424,0.007944,0.009085,0.017280,0.011162,0.005182,0.009039,0.003424,0.010957,0.010797,0.006209,0.009039,0.011391,0.006437,0.005547,0.010843,0.011756,0.003424,0.009085,0.011596,0.011391,0.003424,0.005547,0.011322,0.009039,0.011391,0.006437,0.005615,0.005684,0.005615,0.009108,0.011391,0.003424,0.009085,0.011756,0.003424,0.009291,0.011322,0.011391,0.005273,0.006437,0.005547,0.010843,0.011687,0.009405,0.005250,0.003424,0.007875,0.009131,0.006437,0.003424,0.010843,0.006209,0.003424,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007533,0.007510,0.011502,0.009108,0.008994,0.005615,0.005684,0.005615,0.008994,0.003424,0.007442,0.009291,0.009085,0.007807,0.007898,0.009085,0.011459,0.009656,0.009131,0.007533]},{w:"ments. Our approach poses as an attractive alternative to current multi-step biomarker ",p:[0.117647,0.265324,0.857052,0.265324,0.857052,0.244951,0.117647,0.244951,0.017485,0.009039,0.011391,0.006437,0.007670,0.004497,0.005122,0.016504,0.011413,0.007807,0.005125,0.008811,0.011048,0.011071,0.007442,0.011139,0.009291,0.008765,0.011459,0.005122,0.011505,0.010957,0.007875,0.009039,0.007670,0.005125,0.009291,0.007670,0.005122,0.009085,0.011756,0.005125,0.008811,0.006163,0.006437,0.007898,0.009291,0.009106,0.006437,0.005547,0.009635,0.009039,0.005122,0.009405,0.004908,0.006209,0.009039,0.007807,0.011687,0.008811,0.006437,0.005547,0.009633,0.009039,0.005125,0.006209,0.011048,0.005122,0.009108,0.011413,0.007807,0.007442,0.009039,0.011391,0.006437,0.005125,0.017280,0.011550,0.004908,0.006437,0.005615,0.007533,0.007510,0.006209,0.009131,0.011276,0.005125,0.010820,0.005547,0.010843,0.017577,0.009085,0.007601,0.010272,0.009039,0.007807,0.004109]},{w:"identification assays in lymphoid leukemia, with increased speed and detection sensitiv-",p:[0.117647,0.285903,0.852941,0.285903,0.852941,0.265530,0.117647,0.265530,0.005547,0.011322,0.009039,0.011391,0.006437,0.005615,0.005684,0.005615,0.009108,0.008811,0.006437,0.005547,0.010843,0.011756,0.003926,0.009291,0.007533,0.007944,0.008925,0.009724,0.007670,0.003926,0.005615,0.011756,0.003926,0.005182,0.009724,0.017280,0.011162,0.011299,0.010843,0.005547,0.011391,0.003926,0.005182,0.009131,0.011550,0.010272,0.009039,0.017645,0.005798,0.009291,0.004497,0.003926,0.014723,0.005273,0.006620,0.011459,0.003926,0.005615,0.011598,0.008994,0.007442,0.009288,0.009291,0.007875,0.009108,0.011391,0.003926,0.007510,0.011505,0.009108,0.009108,0.011391,0.003926,0.009085,0.011596,0.011391,0.003926,0.011322,0.009131,0.006209,0.009108,0.009108,0.006437,0.005547,0.010843,0.011756,0.003926,0.007875,0.009039,0.011619,0.007601,0.005273,0.006437,0.005547,0.009836,0.007533]},{w:"ity. ",p:[0.117647,0.306482,0.145952,0.306482,0.145952,0.286109,0.117647,0.286109,0.005273,0.006437,0.007989,0.004497,0.004109]},{w:"Finally, in ",p:[0.117647,0.347639,0.205576,0.347639,0.205576,0.327266,0.117647,0.327266,0.011391,0.005615,0.011687,0.009405,0.005385,0.005184,0.007989,0.004497,0.005296,0.005615,0.011756,0.004109]},{w:"chapter 7",p:[0.206743,0.347639,0.289685,0.347639,0.289685,0.326506,0.206743,0.326506,0.009085,0.011779,0.009542,0.011733,0.006871,0.009268,0.008583,0.005170,0.010911]},{w:" I discussed and reflected on the technological advances presented ",p:[0.289683,0.347639,0.857132,0.347639,0.857132,0.327266,0.289683,0.327266,0.005296,0.007259,0.005296,0.011391,0.005615,0.007875,0.009108,0.011413,0.007533,0.007873,0.009108,0.011391,0.005296,0.009085,0.011596,0.011391,0.005296,0.007442,0.009039,0.005638,0.005570,0.009108,0.009108,0.006209,0.009108,0.011391,0.005296,0.010843,0.011756,0.005296,0.006620,0.011299,0.009039,0.005296,0.006209,0.009108,0.008765,0.011459,0.011596,0.010934,0.005182,0.011048,0.009861,0.005547,0.009108,0.009405,0.005250,0.005296,0.009291,0.011322,0.009838,0.009085,0.011596,0.008994,0.009039,0.007670,0.005296,0.011071,0.007442,0.009039,0.007875,0.009039,0.011391,0.006209,0.009108,0.011391,0.004109]},{w:"in the previous chapters. I explained the advantages of PDO technology in OC research, ",p:[0.117647,0.368218,0.857166,0.368218,0.857166,0.347845,0.117647,0.347845,0.005615,0.011756,0.004086,0.006620,0.011299,0.009039,0.004086,0.011071,0.007442,0.009336,0.009838,0.005547,0.010820,0.011413,0.007670,0.004086,0.008768,0.011391,0.008811,0.011048,0.006209,0.009039,0.007624,0.007670,0.004497,0.004086,0.007259,0.004086,0.009108,0.010089,0.011162,0.005433,0.009085,0.005615,0.011596,0.009108,0.011391,0.004086,0.006620,0.011299,0.009039,0.004086,0.009291,0.011322,0.009838,0.009085,0.011391,0.006551,0.009199,0.009656,0.009039,0.007670,0.004086,0.010843,0.006209,0.004086,0.011662,0.016504,0.016412,0.004086,0.006209,0.009106,0.008768,0.011459,0.011598,0.010934,0.005182,0.011048,0.010544,0.009724,0.004086,0.005615,0.011756,0.004086,0.016778,0.014678,0.004086,0.007442,0.009039,0.007875,0.009291,0.009085,0.007442,0.008765,0.011459,0.004497,0.004109]},{w:"but also the challenges for its further clinical implementation in clinical care. Similarly, I ",p:[0.117647,0.388796,0.857004,0.388796,0.857004,0.368423,0.117647,0.368423,0.010797,0.011071,0.006437,0.004223,0.009402,0.005250,0.007875,0.011048,0.004223,0.006620,0.011299,0.009039,0.004223,0.008765,0.011393,0.009402,0.005387,0.005182,0.009039,0.011459,0.009658,0.009039,0.007670,0.004223,0.006026,0.010843,0.007807,0.004223,0.005271,0.006437,0.007670,0.004223,0.006369,0.011413,0.007967,0.006617,0.011302,0.009039,0.007807,0.004223,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.004223,0.005615,0.017280,0.011162,0.005182,0.009039,0.017485,0.009039,0.011391,0.006551,0.008811,0.006437,0.005547,0.010843,0.011756,0.004223,0.005615,0.011756,0.004223,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.004223,0.009108,0.009085,0.007442,0.008743,0.004497,0.004223,0.010112,0.005615,0.017645,0.005752,0.005430,0.009087,0.007601,0.005182,0.007989,0.004497,0.004223,0.007259,0.004109]},{w:"identify current challenges and propose several solutions for enhancing the knowledge ",p:[0.117647,0.409375,0.857102,0.409375,0.857102,0.389002,0.117647,0.389002,0.005547,0.011322,0.009039,0.011391,0.006437,0.005615,0.006506,0.009724,0.005113,0.009106,0.011413,0.007807,0.007442,0.009039,0.011391,0.006437,0.005113,0.008765,0.011391,0.009405,0.005387,0.005182,0.009039,0.011459,0.009658,0.009039,0.007670,0.005113,0.009085,0.011598,0.011391,0.005113,0.011069,0.007444,0.010820,0.011502,0.010957,0.007875,0.009039,0.005113,0.007875,0.009336,0.009633,0.009039,0.007898,0.009405,0.005250,0.005113,0.007873,0.010936,0.004908,0.011071,0.006437,0.005545,0.010845,0.011619,0.007670,0.005113,0.006024,0.010845,0.007807,0.005113,0.009039,0.011870,0.011391,0.009087,0.011596,0.008994,0.005615,0.011461,0.009861,0.005113,0.006620,0.011302,0.009039,0.005113,0.010703,0.011598,0.010866,0.014789,0.005182,0.009108,0.011391,0.009656,0.009039,0.004109]},{w:"of the role of somatic SVs in cancer and implementation of long-read sequencing. In ",p:[0.117647,0.429954,0.857153,0.429954,0.857153,0.409581,0.117647,0.409581,0.010843,0.006209,0.006437,0.006620,0.011299,0.009039,0.006437,0.007442,0.010934,0.005182,0.009039,0.006437,0.010843,0.006209,0.006437,0.007875,0.010843,0.017577,0.008811,0.006437,0.005547,0.008994,0.006437,0.010112,0.015089,0.007670,0.006437,0.005615,0.011756,0.006437,0.009108,0.009085,0.011596,0.008994,0.009039,0.007807,0.006437,0.009085,0.011598,0.011391,0.006426,0.005615,0.017280,0.011162,0.005182,0.009039,0.017485,0.009039,0.011391,0.006551,0.008811,0.006437,0.005547,0.010843,0.011756,0.006437,0.010840,0.006209,0.006437,0.005179,0.010845,0.011459,0.009861,0.007533,0.007442,0.009288,0.009291,0.011391,0.006437,0.007875,0.009108,0.010706,0.011345,0.009039,0.011596,0.008994,0.005615,0.011459,0.009679,0.004497,0.006437,0.006894,0.011756,0.004109]},{w:"conclusion, this thesis proposes several cancer genomics technological opportunities to ",p:[0.117647,0.450532,0.857070,0.450532,0.857070,0.430160,0.117647,0.430160,0.008994,0.010843,0.011596,0.008765,0.004908,0.011413,0.007601,0.005547,0.010843,0.011756,0.004497,0.004634,0.006620,0.011459,0.005615,0.007670,0.004634,0.006620,0.011299,0.009039,0.007601,0.005615,0.007670,0.004634,0.011071,0.007442,0.010820,0.011505,0.010957,0.007875,0.009039,0.007670,0.004634,0.007873,0.009336,0.009633,0.009039,0.007898,0.009405,0.005250,0.004634,0.009108,0.009085,0.011596,0.008994,0.009039,0.007807,0.004634,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.007670,0.004634,0.006209,0.009108,0.008765,0.011459,0.011596,0.010934,0.005182,0.011048,0.009861,0.005547,0.009108,0.009405,0.005250,0.004634,0.010820,0.011048,0.011505,0.010843,0.007964,0.006166,0.011413,0.011756,0.005271,0.006437,0.005547,0.009039,0.007670,0.004634,0.006209,0.011048,0.004109]},{w:"advance cancer research and develop personalized diagnostic assays to improve patients’ ",p:[0.117647,0.471111,0.857096,0.471111,0.857096,0.450738,0.117647,0.450738,0.009291,0.011322,0.009838,0.009085,0.011596,0.008994,0.009039,0.003721,0.009108,0.009085,0.011596,0.008994,0.009039,0.007807,0.003721,0.007442,0.009039,0.007875,0.009291,0.009085,0.007442,0.008765,0.011459,0.003721,0.009085,0.011596,0.011391,0.003721,0.011322,0.009336,0.009633,0.008948,0.005182,0.010820,0.011276,0.003721,0.011505,0.009039,0.007624,0.007875,0.010843,0.011687,0.009405,0.005250,0.005615,0.008834,0.009106,0.011391,0.003721,0.011391,0.005798,0.009199,0.009861,0.011596,0.010957,0.007510,0.006437,0.005547,0.008994,0.003721,0.009291,0.007533,0.007944,0.008925,0.009724,0.007670,0.003721,0.006209,0.011048,0.003721,0.005615,0.017280,0.011071,0.007442,0.010866,0.009633,0.009039,0.003721,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.006277,0.004291,0.004109]},{w:"outcomes.",p:[0.117647,0.491690,0.204275,0.491690,0.204275,0.471317,0.117647,0.471317,0.010820,0.011071,0.006209,0.008994,0.010843,0.017485,0.009039,0.007670,0.004497]},{w:"210",p:[0.085635,0.957873,0.109682,0.957873,0.109682,0.938882,0.085635,0.938882,0.007923,0.007533,0.008591]},{w:"ADDENDUM",p:[0.117647,0.067543,0.201421,0.067543,0.201421,0.045457,0.117647,0.045457,0.009679,0.010295,0.010295,0.008697,0.010706,0.010295,0.010226,0.013582]}]};